AN2 Therapeutics, Inc. (ANTX)

Market
Nasdaq
Sector
Healthcare
Trend
Downtrend
Last close
3.6 (+1.12% on the day)
MA50
5.16
MA200
3.97
52-week range
1.03–6.28
Market cap
215.5M USD
Dividend yield
0%
Data as of
2026-06-30
Quarterly revenue and earnings, millions of USD
QuarterRevenueYoY %EarningsYoY %
Q1 20250—-10.7—
Q2 20250—-6.5—
Q3 20250—-9.3—
Q4 20250—-8.7—
Q1 20260—-10—
Q2 20260—-8.2—

All markets — KeepWinning global stock screener

Other companies on Nasdaq: Smart Sand, Inc. (SND), Neuronetics, Inc. (STIM), Superior Group of Companies, Inc. (SGC), Fate Therapeutics, Inc. (FATE), Aeon Acquisition I Corp. (AESP), Niagen Bioscience, Inc. (NAGE)